Find a Researcher
Tomoki Hashimoto, MD
Neuro-anesthesiology and Neurobiology
Tomoki Hashimoto, MD, is a professor of neuro-anesthesiology and neurobiology and the director of translational neurovascular research in the Barrow Aneurysm and AVM Research Center. He is board certified in anesthesiology by the American Board of Anesthesiology.
Dr. Hashimoto’s expertise includes clinical anesthesiology and vascular biology. He earned his medical degree from Gifu University School of Medicine in Japan. He received his residency training in anesthesia at Gifu University Hospital, Thomas Jefferson University Hospital in Philadelphia, and NewYork-Presbyterian/Columbia University Medical Center. He completed a clinical fellowship at NewYork-Presbyterian/Columbia Medical Center and a research fellowship at the University of California-San Francisco, both in neuro-anesthesia.
Dr. Hashimoto leads a program that focuses on the translational research of cerebrovascular diseases. His group studies the roles of inflammation and vascular remodeling in the pathophysiology of intracranial aneurysms and brain arteriovenous malformations. They are developing pharmacological therapies for the prevention of stroke caused by rupture of intracranial aneurysms and brain arteriovenous malformations.
- Research Fellow, University of California-San Francisco, Neuro-anesthesia, 2000-2001
- Fellow, NewYork-Presbyterian/Columbia Medical Center, Neuro-anesthesia, 1999-2000
- Resident, NewYork-Presbyterian/Columbia Medical Center, Anesthesia, 1997-1999
- Resident, Thomas Jefferson University Hospital, Anesthesia, 1996-1997
- Internship, Chestnut Hill Hospital, 1995-1996
- Resident, Gifu University Hospital, Anesthesia, 1992-1995
- MD, Gifu University, School of Medicine, 1992
- American Heart Association
- American Society of Anesthesiologists
- Association of University Anesthesiologists
- Fellow of the American Heart Association, 2013
- Pfizer Health Care Research Scholarship, 1997
- Noguchi Medical Research Institute Scholarship for U.S.A. Visiting Program, 1994
- Noguchi Medical Research Institute Scholarship for U.S.A. Short Visiting Program, 1993
Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin II
Date: 03/2023
Authors: Keisuke Okuno, Keiichi Torimoto, Stephanie M. Cicalese, Kyle Preston, Victor Rizzo, Tomoki Hashimoto, Nobuo Hashimoto, Thomas M. Coffman, Matthew A. Sparks, Satoru Eguchi
Smooth muscle angiotensin II type 1A receptor is required for abdominal aortic aneurysm formation induced by angiotensin II plus β-aminopropionitrile
Date: 03/2023
Authors: Keisuke Okuno, Keiichi Torimoto, Stephanie M. Cicalese, Tomoki Hashimoto, Matthew A. Sparks, Victor Rizzo, Satoru Eguchi
Endoplasmic Reticulum Chemical Chaperone 3-Hydroxy-2-Naphthoic Acid Reduces Angiotensin II-Induced Vascular Remodeling and Hypertension In Vivo and Protein Synthesis In Vitro
Date: 12/2022
Authors: Stephanie Cicalese, Keiichi Torimoto, Keisuke Okuno, Katherine J. Elliott, Victor Rizzo, Tomoki Hashimoto, Nobuo Hashimoto, Satoru Eguchi
Intracranial aneurysm calcification - A narrative review
Date: 07/2022
Authors: Redi Rahmani, Jacob F. Baranoski, Felipe C. Albuquerque, Michael T. Lawton, Tomoki Hashimoto
Angiotensin II inhibition: a potential treatment to slow the progression of sarcopenia
Date: 11/2021
Authors: Jeffrey Kingsley, Keiichi Torimoto, Tomoki Hashimoto, Satoru Eguchi
Tomoki Hashimoto, MD
Neuro-anesthesiology and Neurobiology
Tomoki Hashimoto, MD, is a professor of neuro-anesthesiology and neurobiology and the director of translational neurovascular research in the Barrow Aneurysm and AVM Research Center. He is board certified in anesthesiology by the American Board of Anesthesiology.
Dr. Hashimoto’s expertise includes clinical anesthesiology and vascular biology. He earned his medical degree from Gifu University School of Medicine in Japan. He received his residency training in anesthesia at Gifu University Hospital, Thomas Jefferson University Hospital in Philadelphia, and NewYork-Presbyterian/Columbia University Medical Center. He completed a clinical fellowship at NewYork-Presbyterian/Columbia Medical Center and a research fellowship at the University of California-San Francisco, both in neuro-anesthesia.
Dr. Hashimoto leads a program that focuses on the translational research of cerebrovascular diseases. His group studies the roles of inflammation and vascular remodeling in the pathophysiology of intracranial aneurysms and brain arteriovenous malformations. They are developing pharmacological therapies for the prevention of stroke caused by rupture of intracranial aneurysms and brain arteriovenous malformations.
- Research Fellow, University of California-San Francisco, Neuro-anesthesia, 2000-2001
- Fellow, NewYork-Presbyterian/Columbia Medical Center, Neuro-anesthesia, 1999-2000
- Resident, NewYork-Presbyterian/Columbia Medical Center, Anesthesia, 1997-1999
- Resident, Thomas Jefferson University Hospital, Anesthesia, 1996-1997
- Internship, Chestnut Hill Hospital, 1995-1996
- Resident, Gifu University Hospital, Anesthesia, 1992-1995
- MD, Gifu University, School of Medicine, 1992
- American Heart Association
- American Society of Anesthesiologists
- Association of University Anesthesiologists
- Fellow of the American Heart Association, 2013
- Pfizer Health Care Research Scholarship, 1997
- Noguchi Medical Research Institute Scholarship for U.S.A. Visiting Program, 1994
- Noguchi Medical Research Institute Scholarship for U.S.A. Short Visiting Program, 1993
Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin II
Date: 03/2023
Authors: Keisuke Okuno, Keiichi Torimoto, Stephanie M. Cicalese, Kyle Preston, Victor Rizzo, Tomoki Hashimoto, Nobuo Hashimoto, Thomas M. Coffman, Matthew A. Sparks, Satoru Eguchi
Smooth muscle angiotensin II type 1A receptor is required for abdominal aortic aneurysm formation induced by angiotensin II plus β-aminopropionitrile
Date: 03/2023
Authors: Keisuke Okuno, Keiichi Torimoto, Stephanie M. Cicalese, Tomoki Hashimoto, Matthew A. Sparks, Victor Rizzo, Satoru Eguchi
Endoplasmic Reticulum Chemical Chaperone 3-Hydroxy-2-Naphthoic Acid Reduces Angiotensin II-Induced Vascular Remodeling and Hypertension In Vivo and Protein Synthesis In Vitro
Date: 12/2022
Authors: Stephanie Cicalese, Keiichi Torimoto, Keisuke Okuno, Katherine J. Elliott, Victor Rizzo, Tomoki Hashimoto, Nobuo Hashimoto, Satoru Eguchi
Intracranial aneurysm calcification - A narrative review
Date: 07/2022
Authors: Redi Rahmani, Jacob F. Baranoski, Felipe C. Albuquerque, Michael T. Lawton, Tomoki Hashimoto
Angiotensin II inhibition: a potential treatment to slow the progression of sarcopenia
Date: 11/2021
Authors: Jeffrey Kingsley, Keiichi Torimoto, Tomoki Hashimoto, Satoru Eguchi